zydus cadila covid vaccine in india: get vaccinated without a needle; Psychov d vaccine has immediate approval: zydus cadila’s three-dose covid-19 vaccine, zycov-d has dcgi approval for emergencies


  • Permission for immediate use of the Sykov D vaccine.
  • The permit was granted by the CCGI.
  • Psychov d for the sixth Kovid vaccine in the country.

New Delhi: The Comptroller General of Drugs of India (CCGI) has given immediate approval to Sydus Cadillac’s ‘Psychov D’ Kovid vaccine. The action is based on the recommendation of the expert committee. The vaccine has been tested in more than 28,000 people. With this, Psychov d.

Also Read:  tomato price rise india: tomato price rises: wholesale price rises from 2.5 rupees to 22 rupees - tomato prices rise in india

Unlike other vaccines, this vaccine can be given in three doses. The vaccine, which can be administered to children older than 12 years, is 66.66% effective. This is the first time in the country that a vaccine for injection in children over 12 years of age has been approved.

The vaccine is injected into the skin without the use of a needle. Sydus says the side effects are minor because the needle is not used. On July 1, Ahmedabad-based pharmaceutical company Sydus Cadila submitted a request for an urgent use of the vaccine. After this, permission was granted.

Also Read:  Mumbai Zero Covid Deaths: How did the city of Mumbai accomplish this feat? - Maharashtra Mumbai records zero covid deaths during the holidays

Sydus Cadila said it plans to produce between 100 million doses and 120 million doses per year. Company officials said it had started stockpiling the vaccine. The company claims that two doses of the three-dose vaccine have the same effect as those of the three-dose vaccine. Psychov d is the second Kovid vaccine manufactured locally in India after Kovax from Bharat Biotech.

Now hope is Onam; Papaya manufacturers with the belief that the market will wake up

Also Read:  All eyes are back on Galvan Valley

Related Articles

Back to top button